Biotechnology News

September 24, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US & UKMedical Media Only Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) will present data for three molecules, including two investigational compounds, from their...

September 24, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, a personalized medicine biotechnology company, appoints senior industry veteran Laura A. Brege as President and Chief Executive Officer.

September 24, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals provides update on anticipated milestones for pivotal, registrational BELIEF trial of belinostat.

September 24, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi announced that dosing with their first drug was completed last week.

September 24, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) claiming the...

September 24, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. Reports Oral FluCide™ Is Highly Effective Against H3N2 Influenza A Virus and Superior to Tamiflu® based on Increased Survival. The Company believes FluCide is broad-spectrum.

September 24, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Receives FDA 510(k) Clearance for ARROW FlexBlock Continuous Peripheral Nerve Block Catheter

September 24, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Sanofi has selected BioClinica's OnPoint as its Enterprise CTMS, and plans to use OnPoint CTMS for all clinical trial management activity.

September 24, 2012

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--ASCC Initiates Trials on Biomolecule Skin Cream

September 24, 2012

TOKYO--(BUSINESS WIRE)--Sumitomo Electric will provide a dynamic exhibition of the Compovision near-infrared camera at P-MEC Europe held on October 9 to 11, 2012, part of the global portfolio of pharmaceutical events.

September 24, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For NON-U.S Health Media Only Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib* (150 mg twice...

September 21, 2012

ROCHESTER, N.Y. & BILLERICA, Mass.--(BUSINESS WIRE)--Carestream Health and Bruker have entered into an agreement for Bruker to purchase the preclinical in-vivo imaging equipment product portfolio and related assets from Carestream’s Molecular...

September 21, 2012

--(BUSINESS WIRE)--G1 Therapeutics, Inc. is a privately held pharmaceutical company based in Chapel Hill, NC, that focuses on the discovery and development of novel small molecules for use in cancer therapy and biodefense applications. These...

September 21, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--RSA, the leading global Life Sciences Executive Search and Interim Management specialist, is pleased to announce the placement of Jack Talley as President and CEO of Actinium Pharmaceuticals, Inc.

September 21, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium today announced that Science magazine has named it among the best biopharmaceutical employers in the world for the fifth consecutive year.

September 21, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, today announced that its Portex® CorrectInject™ Safety System for administering neuraxial (spinal and epidural) medication received 510(k) clearance...

September 21, 2012

NASHVILLE, Tenn. & NEW YORK--(BUSINESS WIRE)--Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to Develop Novel Treatments for Parkinson’s Disease

September 21, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that the William E. Proudford Sickle Cell...

September 21, 2012

BARCELONA, Spain & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive...

September 21, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

September 21, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced the appointment of Jonathan I. Lieber to the position of Chief Financial Officer and Treasurer, effective immediately. Mr. Lieber most recently held the position...

September 21, 2012

WASHINGTON, United States--(BUSINESS WIRE)--Scottish scientists are homing in on the elusive genes that could create the perfect salmon and revolutionise aquaculture. Experts at Landcatch Natural Selection, based in Argyll, and their research...

September 21, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC): Thursby Software Systems and an additional recognized partner have together placed orders exceeding one thousand Tactivo™ units for delivery in Q4, 2012. Tactivo enhances...

September 20, 2012

NEWARK, Calif.--(BUSINESS WIRE)--Oraya Therapeutics, Inc. today announced that the results of the INTREPID trial of radiation therapy for wet AMD were first presented during the 12th EURETINA Congress in Milan, Italy.

September 20, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics announces that it has been granted multiple patents for its multiplexing platform and assay technologies

September 20, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) today announced the appointment of Hans Peter Hasler as Chief Operating Officer (“COO”) of the Company with effect from October 1, 2012. Mr. Hasler is currently a non-executive director of...

September 20, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported an independent pilot study conducted in the U.K. showed that MEDIHONEY® may reduce...

September 20, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 16% increase in the quarterly dividend rate, from $0.225 per ordinary share to $0.26 per ordinary share.

September 20, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Awarded SBIR Grant from the NIH for Development of Radio-Immuno-Guided Surgery (RIGS) Agent Aimed at Detecting Metastatic Cancer

September 20, 2012

SAN DIEGO--(BUSINESS WIRE)--Endometrial regenerative cells (ERC) are a new type of stem cell that are universal donor, meaning that they do not require matching, and are currently in clinical trials for heart failure

September 20, 2012

GREENWICH, Conn. & PURCHASE, N.Y.--(BUSINESS WIRE)--Sagard Capital Partners, L.P. (“Sagard Capital”) and IntegraMed America, Inc. (NASDAQ: INMD) (“IntegraMed”), a leader in developing, marketing and managing specialty healthcare facilities in...

September 20, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, reports on a recent press release by the San Francisco NBC news, with new...

September 20, 2012

EVRY, France--(BUSINESS WIRE)--Global Bioenergies, the industrial biology company developing sustainable routes to light olefins, has been selected by EuropaBio, the organization representing more than 1800 European companies, to receive the “...

September 20, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Phase 3 Meta-Analysis Data at the 32nd Congress of the European Society of Surgical Oncology

September 20, 2012

BOSTON--(BUSINESS WIRE)--Jeffrey M. Wiesen, a Member of Mintz Levin and Chair of the firm’s Life Sciences Practice, has been named the Best Lawyers’ 2013 Boston Biotechnology Law “Lawyer of the Year.”

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today two recent...

September 20, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that it has been granted a six month extension until March 18, 2013 of the grace...

September 20, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics hosted an international conference on galectins and disease September 17-19. The proceedings will be published in early 2013.

September 20, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech President, Mike Klein to present at Michigan HIMSS Chapter HITECH Fall Conference in Detroit, Michigan.

September 20, 2012

PARIS--(BUSINESS WIRE)--The international jury under the presidency of Professor Iain Robinson (National Institute for Medical Research, London, UK) awarded on September 12th, 2012, the 11th Endocrine Regulation Prize of the Fondation Ipsen (20....

September 20, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced that Chief Executive Officer Michael L. Krall is schedule to present at the Aegis Capital...

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND appoints Daniel S. Lynch as Chairman of the company’s board of directors.

September 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Updated Infosario brings The Data Driven Difference™– to harnessing the power of data from diverse sources in near real-time to help customers make the best possible decisions

September 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new study finds that, on average, drug companies dedicate more money to market research prior to launch than any other pharmaceutical marketing activity, according to Cutting Edge Information.

September 20, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today the passing of one of its Board Members, Gregory H. Barnhill. Mr. Barnhill has served on Osiris’ Board of Directors since the company went public in August...

September 20, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics announces agenda for its Investor Day event on Oct.9. Safeguard is going green to minimize impact on the environment... RSVP by Oct.5 at...